Patent · US Active

PRMT5 inhibitors

US11993602B2 · kind B2 · utility

0Cited by
82References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2019
Grant dateMay 28, 2024
Priority date—
Expiry dateFeb 18, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides a compound of Formula (I) Formula (I) or the pharmaceutically acceptable salts thereof, which are PRMT5 inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.